会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • MONITORING DEVICE
    • 监控设备
    • US20090033743A1
    • 2009-02-05
    • US12188448
    • 2008-08-08
    • Thomas Gruber-NadlingerArmin Bauer
    • Thomas Gruber-NadlingerArmin Bauer
    • H04N7/18
    • G03B17/02
    • A device for monitoring objects, in particular for monitoring industrial environments, such as paper mills and manufacturing and/or finishing processes of a paper, board or other fibrous web being carried out therein, includes a monitoring camera, the camera with its objective being arranged in a rotationally symmetrical protective housing rotating about an axis of rotation, and a protective housing to be mounted at its one end on a rigid hollow shaft and, at its coaxially opposite other end, to have a co-rotating blower pipe or merge into the latter, and for compressed air to be applied to the protective housing, including the blower pipe.
    • 一种用于监测物体的装置,特别是用于监测工业环境,例如造纸厂以及在其中执行的纸,板或其它纤维网的制造和/或整理过程,包括监控摄像机,其目的是布置在摄像机 在围绕旋转轴线旋转的旋转对称的保护壳体中,以及保护壳体,其一端安装在刚性中空轴上,并且在其同轴地相对另一端处具有同向旋转的鼓风机管道或合并到 并且用于压缩空气被施加到包括鼓风机管道的保护壳体。
    • 9. 发明授权
    • Pyrrole-derivatives as factor Xa inhibitors
    • 吡咯衍生物作为因子Xa抑制剂
    • US07465806B2
    • 2008-12-16
    • US11467277
    • 2006-08-25
    • Armin BauerMichael WagnerMarc NazareVolkmar WehnerMatthias UrmannHans Matter
    • Armin BauerMichael WagnerMarc NazareVolkmar WehnerMatthias UrmannHans Matter
    • C07D261/06C07D207/32
    • C07D401/12C07D401/14C07D413/14
    • The present invention relates to compounds of the formulae I and Ia, wherein R0; R1; R3; R4; R22, Q; V, G and M have the meanings indicated in the claims. The compounds of the formulae I and Ia are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses. They are reversible inhibitors of the blood clotting enzymes factor Xa (FXa) and/or factor VIIa (FVIIa), and can in general be applied in conditions in which an undesired activity of factor Xa and/or factor VIIa is present or for the cure or prevention of which an inhibition of factor Xa and/or factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of the formulae I and Ia, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.
    • 本发明涉及式I和Ia的化合物,其中R 0; R1; R3; R4; R22,Q; V,G和M具有权利要求中所示的含义。 式I和Ia的化合物是有价值的药理活性化合物。 它们具有强烈的抗血栓形成作用,适用于治疗和预防心血管疾病如血栓栓塞性疾病或再狭窄。 它们是血液凝固酶因子Xa(FXa)和/或因子VIIa(FVIIa)的可逆抑制剂,并且通常可用于存在因子Xa和/或因子VIIa的不期望活性或用于治愈 或预防因子Xa和/或因子VIIa的抑制。 本发明还涉及制备式I和Ia化合物的方法,其用途,特别是作为药物中的活性成分,以及包含它们的药物制剂。